Bel and Lou - the Point of Care TTANGO program

The TTANGO training manual developed by our Centre

TTANGO point of care testing


TTANGO logo TTANGO (Test, Treat ANd Go) is a randomised trial that aims to measure the effectiveness, cost-effectiveness and cultural and operational acceptability of point-of-care testing for chlamydia and gonorrhoea infections in remote Aboriginal communities. The trial utilises the GeneXpert CT/NG (Cepheid), a new point-of-care testing device that employs nucleic acid amplification technology to accurately detect chlamydia and gonorrhoea.

The Kirby Institute (University of NSW) were awarded an NHMRC grant to fund the TTANGO clinical trial. The Centre’s Director, Professor Shephard is a Chief Investigator on this project.

The trial commenced mid 2011 in 12 remote Aboriginal communities across Australia.

For more information go to the Kirby Institute website.

Who’s involved?

Principal Investigator

R Guy, Kirby Institute

Researchers from Our Centre

M Shephard (CI from 2012)
L Motta


  • J Ward, Baker IDI Central Australia,
  • D Whiley, Queensland Paediatric Infectious Diseases (QPID) Laboratory, Royal Children’s Hospital
  • S Tabrizi, Royal Women’s Hospital
  • B Donovan, Kirby Institute
  • J Kaldor, Kirby Institute
  • C Fairley, University of Melbourne/Melbourne Sexual Health Centre
  • D Wilson, Kirby Institute
  • D Regan, Kirby Institute
  • H Wand, Kirby Institute
  • D Anderson, Burnet Institute
  • L Natoli, Burnet Institute
  • B Hengel, Apunipima Health Council
  • A Tangey, Ngaanyatjarra Health Service
  • S Badman, Kirby Institute
  • L Causer, Kirby Institute


Our Centre's role

Our Centre was asked to participate in TTANGO because we have knowledge and expertise in establishing and operating point-of-care testing field programs in Australian Indigenous communities in a culturally safe manner. We also have resource and teaching interests in POCT for infectious diseases.


The TTANGO training manual developed by our Centre

Pictured above: The TTANGO training manual developed by our Centre for the trial.